Form D Explorer

Form D — Antares Therapeutics, Inc.

0002059043-25-000002 · filed 2025-05-15

Offering

Industry: Biotechnology
Exemptions: 06b
Total offering: $136,650,000
Total sold: $30,000,000
Minimum investment: $0
Investors: —
Sales commission: —
Finders' fees: —

Issuer

Name: Antares Therapeutics, Inc.
CIK: 2059043
Entity: Corporation
Jurisdiction: DELAWARE
Year incorporated: 2025
Address: ONE WINTHROP SQUARE, SUITE 400
BOSTON, MA 02110
Phone: 781-288-5760

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Adam Friedman · Executive Officer

Boston, MA Find on LinkedIn ↗
Shelley Chu · Director

Boston, MA Find on LinkedIn ↗
Keith Flaherty · Director

Boston, MA Find on LinkedIn ↗
Jeffrey Albers · Director

Boston, MA Find on LinkedIn ↗
Brian Piper · Executive Officer

Boston, MA Find on LinkedIn ↗
Andrew Fedder · Executive Officer

Boston, MA Find on LinkedIn ↗
Jean-Francois Formela · Director

Boston, MA Find on LinkedIn ↗
Menelas N. Pangalos · Director

Boston, MA Find on LinkedIn ↗

View original on SEC EDGAR.